USNA · Usana Health Sciences
AI read · Neutral
The AI's read
Lower event and compensation costs helped improve operating profitability, and Southeast Asia Pacific returned to sales growth. Haya also improved as customer acquisition costs fell. But Greater China remained difficult, and declining Rise club orders led to a lower sales outlook. Usana has no debt and expects about $77 million in adjusted EBITDA, a company profit measure, but the gains and setbacks leave the report mixed.